I-COVID-19 IgM/IgG I-Lateral Flow Assay
Isingeniso Somkhiqizo
I-Virusee® COVID-19 IgM/IgG Lateral Flow Assay iyi-lateral flow immunoassay esetshenziselwa ukutholwa kwe-in vitro qualitative ye-novel coronavirus (SARS-CoV-2) IgM / IgG amasosha omzimba egazini lomuntu lonke, i-plasma, ne-serum.
I-coronavirus yenoveli iyigciwane le-RNA elinomucu owodwa.Ngokungafani nanoma iyiphi i-coronavirus eyaziwayo, inani labantu abasengcupheni ye-Novel Coronavirus livame ukungenwa kalula, futhi lisongela abantu abadala noma abantu abanezifo ezibalulekile.Amasosha omzimba e-IgM/IgG ayinkomba ebalulekile yenoveli yokutheleleka nge-coronavirus.Ukutholwa kwamasosha omzimba aqondene ne-coronavirus kuzosiza ekuxilongweni komtholampilo.
Izici
| Igama | I-COVID-19 IgM/IgG I-Lateral Flow Assay |
| Indlela | I-Lateral Flow Assay |
| Uhlobo lwesampula | Igazi, i-plasma, i-serum |
| Ukucaciswa | Izivivinyo ezingama-20/ikhithi |
| Isikhathi sokutholwa | 10 imiz |
| Izinto zokutholwa | I-COVID-19 |
| Ukuzinza | Ikhithi izinzile unyaka ongu-1 ku-2-30°C |
Inzuzo
- Ngokushesha
Thola umphumela phakathi kwemizuzu eyi-10 - Kulula
Umphumela wokufunda obonakalayo, kulula ukuwuhumusha
Inqubo elula, ngaphandle kokusebenza okuyinkimbinkimbi
- Ukonga izindleko
Umkhiqizo ungathuthwa futhi ugcinwe ekamelweni lokushisa, ukunciphisa izindleko - Ingozi ephansi
Ukuhlola isampula yegazi, kunciphisa ingcuphe yenqubo yesampula - Ifanele ukuhlolwa endaweni, eceleni kombhede, isiguli esingaphandle
Isendlalelo kanye nesimiso
I-novel coronavirus, i-acute acute respiratory syndrome (SARS-CoV)-2, ikhonjwe njengembangela yesifo se-coronavirus 2019 (COVID-19).Lesi sifo sibizwa ngokuthi isimo esiphuthumayo sezempilo yomphakathi esikhathaza amazwe ngamazwe yi-World Health Organization (WHO).
I-COVID-19 iqondise kumasistimu okuphefumula aphezulu naphansi futhi ibangela izimpawu ezinjengomkhuhlane kubantu abaningi abanaleli gciwane.Yize iziguli eziningi ze-COVID-19 zithola izimpawu ezithambile kuphela, ezinye iziguli zinezimpawu ezinzima eziholela ekulimaleni okukhulu kwamaphaphu.Izinketho zokwelapha i-COVID-19 zikhawulelwe futhi izinga lokufa okungafanele lilinganiselwa yi-WHO licishe libe ngu-2.9%.Yize umuthi wokugomela i-COVID-19 ungagcina utholakala, ngaphandle uma kutholakala ukuzivikela okwanele komhlambi, i-COVID-19 ingase ibangele ukugula nokufa okukhulu eminyakeni ezayo.
Ngemva kokuphathwa ukutheleleka, kuvamile ukwakha impendulo ye-antibody ngokumelene ne-pathogen ethile.Ngokushesha ngemva kokutheleleka (imvamisa ngemva kwesonto lokuqala), ikilasi lamasosha omzimba elaziwa ngokuthi i-immunoglobulin M (IgM) liyakhula, nakuba lokhu ngokuvamile kungapheli isikhathi eside.Kamuva, ngemva kwamasonto angu-2-4 okuqala ngemva kokutheleleka, i-IgG, i-antibody eqinile, iyakhiqizwa.
Ucwaningo luthole ukuthi amasosha omzimba aqondiswe ku-RBD ayizimpawu ezinhle kakhulu zokutheleleka kwangaphambilini kanye nakamuva, ukuthi izilinganiso ze-isotype ezihlukene zingasiza ukuhlukanisa phakathi kwezifo zakamuva kanye nezindala.Ukutholwa kwamasosha omzimba e-IgM ne-IgG ngokumelene ne-SARS-CoV-2 kunokubaluleka okungaba khona ekuhloleni ubukhali kanye nokubikezelwa kwe-COVID-19, ngisho nokukhulisa ukunemba kokutholwa kokuhlolwa kwe-nuclear acid.
Ukutholwa kwe-SARS-CoV-2 IgM ne-IgG kubaluleke kakhulu ukuze kunqunywe inkambo ye-COVID-19.Ukutholwa kwe-Nucleic acid kuhlanganiswe ne-serum antibody ye-SARS-CoV-2 kungase kube inkomba engcono kakhulu yaselabhorethri yokuhlonza ukutheleleka kwe-SARS-CoV-2 kanye nebinzana nesibikezelo sokubikezela kwe-COVID-19.
Inqubo yokuhlola
Oda Ulwazi
| Imodeli | Incazelo | Ikhodi yomkhiqizo |
| VMGLFA-01 | 20 test/kit, ifomethi yekhasethi | I-CoVMGLFA-01 |
